Medical Market Report

Global Aurora Kinase B Market By Type (AZD-2811, CS-2164, Danusertib, Ilorasertib, and NMI-900), By Application (Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, and Prostate Cancer), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 137970
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Aurora Kinase B Market is estimated to be valued US$ XX.X million in 2019. The report on Aurora Kinase B Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global aurora kinase b market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Aurora Kinase B Market Scope:

    By type, the market is segmented into AZD-2811, CS-2164, Danusertib, Ilorasertib, and NMI-900. By Application, the market is divided into Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, and Prostate Cancer.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, and Sareum Holdings Plc.

    Key Market Segments

    Type

    AZD-2811

    CS-2164

    Danusertib

    Ilorasertib

    NMI-900

    Application

    Anaplastic Large Cell Lymphoma

    Kidney Cancer

    Lung Cancer

    Prostate Cancer

    Key Market Players included in the report:

    AbbVie Inc

    Advenchen Laboratories LLC

    Aeterna Zentaris Inc

    Amgen Inc

    AstraZeneca Plc

    Chipscreen Biosciences Ltd

    Cielo Therapeutics Inc

    Sanofi

    Sareum Holdings Plc

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Aurora Kinase B Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Aurora Kinase B Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Aurora Kinase B Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Aurora Kinase B Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Aurora Kinase B Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Aurora Kinase B Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Aurora Kinase B sub-markets, depending on key regions (various vital states).
    To analyze Aurora Kinase B Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Aurora Kinase B Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Aurora Kinase B Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Aurora Kinase B Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Aurora Kinase B Market Overview
    

    3.1. Aurora Kinase B Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Aurora Kinase B Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Aurora Kinase B Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. AZD-2811
    

      4.4. CS-2164
    

      4.5. Danusertib
    

      4.6. Ilorasertib
    

      4.7. NMI-9005. Global Aurora Kinase B Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Aurora Kinase B Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Anaplastic Large Cell Lymphoma
    

      5.4. Kidney Cancer
    

      5.5. Lung Cancer
    

      5.6. Prostate Cancer6. Global Aurora Kinase B Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Aurora Kinase B Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Aurora Kinase B Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Aurora Kinase B Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Aurora Kinase B Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Aurora Kinase B Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Aurora Kinase B Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. AbbVie Inc
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Advenchen Laboratories LLC
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Aeterna Zentaris Inc
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Amgen Inc
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. AstraZeneca Plc
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Chipscreen Biosciences Ltd
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Cielo Therapeutics Inc
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Sanofi
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Sareum Holdings Plc
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.